SAN DIEGO--(BUSINESS WIRE)-- RxMD, Inc., a privately-held, global therapeutics development company, today announced a collaboration agreement with GlycoRegImmune Inc. (GRI) to develop new treatments ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

RXMD has finally finished another quarter and her investors are eager to see the further progress the company has made. Year over year, month after month, RXMD has been exceeding their growth goals.

MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary, RXMD ...

Another milestone achieved. Audited financials. Long awaited stock trend reversal. When I last wrote about Progressive Care here the stock trend was still headed lower. This trend began in March of ...

AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, today announced that a new audio ...

Startup biotech is developing type I NKT inhibitors and type II NKT modulators against inflammatory and autoimmune diseases. GlycoRegImmune (GRI) has teamed up with RxMD to progress a pipeline of ...

E-commerce provider NextPlat Corp NXPL said it had made a $7 million investment in Progressive Care Inc RXMD, a healthcare services and technology company. Under its recapitalization plan, the company ...

The positions in the table below reflect the Rx Medical Dynamics (RXMD)'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...

Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending. Nasdaq Data provided by Nasdaq ...